|
RAB12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.166100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.155900E-02 |
| Normal-vs-Stage2 |
1.283880E-02 |
| Normal-vs-Stage3 |
7.388500E-02 |
| Normal-vs-Stage4 |
2.124200E-01 |
| Stage1-vs-Stage2 |
2.681400E-01 |
| Stage1-vs-Stage3 |
6.647600E-01 |
| Stage1-vs-Stage4 |
4.241400E-01 |
| Stage2-vs-Stage3 |
2.016600E-01 |
| Stage2-vs-Stage4 |
1.277960E-01 |
| Stage3-vs-Stage4 |
6.636600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.716500E-03 |
| Normal-vs-AfricanAmerican |
6.311200E-01 |
| Normal-vs-Asian |
3.094000E-01 |
| Caucasian-vs-AfricanAmerican |
6.155500E-02 |
| Caucasian-vs-Asian |
5.267400E-01 |
| AfricanAmerican-vs-Asian |
2.588200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.327360E-01 |
| Normal-vs-Female |
1.370290E-02 |
| Male-vs-Female |
2.199400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.096330E-02 |
| Normal-vs-Age(41-60Yrs) |
5.247500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.784300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.554200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.771600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.824800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.168000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.508000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.952200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.668800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.610800E-01 |
| Classical-VS-Follicular |
1.393220E-04 |
| Classical-VS-Other |
4.729800E-01 |
| Classical-VS-Normal |
2.357800E-01 |
| Tall-VS-Follicular |
5.380300E-02 |
| Tall-VS-Other |
7.787000E-01 |
| Tall-VS-Normal |
1.161390E-01 |
| Follicular-VS-Other |
2.663400E-01 |
| Follicular-VS-Normal |
4.169000E-04 |
| Other-VS-Normal |
2.602400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.719300E-03 |
| Normal-vs-N1 |
4.159200E-01 |
| N0-vs-N1 |
4.627500E-02 |
|
|
